
Keywords: پلیمورفیسم تک نوکلئوتید (SNP); Single nucleotide polymorphism (SNP); Molecular dynamics simulation (MD); HINT score; Multiple sclerosis; Natalizumab; Pharmacogenetics; MS; Multiple Sclerosis; SNP; single nucleotide polymorphism; nsSNP; non-synonymous single nucleotide polymorphism; MD;